Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Cases of severe gastrointestinal toxicity were monitored prospectively during NSABP
C-07, a randomized clinical trial of adjuvant therapy for patients with stage II/III
colon cancer.